Earnings calls

RPG LifeScience. concall ledger

Every earnings call for RPGLIFE — management tone, guidance, KPIs and promise tracking, quarter by quarter.

RPGLIFE · 2 transcripts · Healthcare · latest Q2 FY26

Q2 FY26Published 17 Oct 2025Call held 17 Oct 2025

RPGLIFE Q2 FY26 Earnings Call Transcript & Analysis

EBITDA₹43.6 crEBITDA Margin24%PBT—

EBITDA ₹44 cr; EBITDA Margin 24.0%. Revenue from operations up 7.6% QoQ to INR181.7 crores.

Q4 FY25Published 29 Apr 2025Call held 29 Apr 2025

FY25 EBITDA Margin26.4%FY25 PAT Margin17.1%

FY25 EBITDA Margin 26.4%; FY25 PAT Margin 17.1%. Q4 FY25 business growth of 12.7%, 1.6x of market growth.